Biocon signs pact with Mylan

Monday, 29 June 2009, 21:13 IST
Printer Print Email Email
Bangalore: Indian biotechnology major Biocon Monday said it had signed an agreement with Mylan. to develop, manufacture and supply generic biologic drugs globally. Mylan is a leading diversified generics and specialty pharmaceutical company. "Through this partnership we hope to deliver high quality, affordable bio-generic antibodies and biologics, thereby addressing a critical need to lower spiralling healthcare costs in both the developed and emerging economies," said Kiran Mazumdar Shaw, chairperson and managing director, Biocon. As part of this agreement, both the companies will share development, capital and certain other costs to bring the products to the market.
Source: IANS